Papers
8
Total Citations
2,059
H-Index
7
About
Paul Russo is a leading urologic oncologist whose research has fundamentally shaped the surgical management of kidney cancer. His work centers on optimizing treatment for renal masses, particularly through the development and refinement of nephron-sparing surgery. Dr. Russo’s most influential contribution is his seminal 2009 guideline for managing clinical T1 renal masses, which has amassed over 1,800 citations and serves as a cornerstone for clinical decision-making worldwide. He has been a driving force in comparing open, laparoscopic, and robotic partial nephrectomy, demonstrating the safety and efficacy of minimally invasive approaches for tumors 4–7 centimeters. To standardize surgical planning, he has advanced the use of nephrometry scoring systems like R.E.N.A.L. and PADUA, and his work on cost comparisons and ischemia techniques (warm vs. cold) has improved perioperative outcomes. More recently, Dr. Russo has tackled rare but critical complications, including atypical tumor recurrences and tumor rupture during robotic surgery, leading the international RUPTURE Project to establish consensus guidelines. With a career spanning decades, his research has directly improved patient outcomes by balancing oncologic control with renal function preservation.
Research Focus
Key Achievements
Top Papers
- 1Guideline for Management of the Clinical T1 Renal Mass1,839 citations · 2009
- 2
- 3
- 4
- 5
- 6
- 7
- 8